Categories : Respiratory System
Product Packaging : 10 / 30 tablets
Product Composition : 800 mg
Doxofylline Sustained-Release tablets are bronchodilator formulations designed to provide prolonged relief in respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The sustained-release mechanism ensures controlled and extended drug release, helping maintain consistent therapeutic levels and improving breathing function over an extended period.
In international pharmaceutical markets, Doxofylline sustained release tablets exporter India and SR bronchodilator tablet supplier India pharma are widely searched by respiratory medicine distributors and importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India respiratory medicines partner, offering high-quality sustained-release formulations for global healthcare supply.
Send MessageDoxofylline Sustained-Release tablets are bronchodilator formulations designed to provide prolonged relief in respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The sustained-release mechanism ensures controlled and extended drug release, helping maintain consistent therapeutic levels and improving breathing function over an extended period.
In international pharmaceutical markets, Doxofylline sustained release tablets exporter India and SR bronchodilator tablet supplier India pharma are widely searched by respiratory medicine distributors and importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India respiratory medicines partner, offering high-quality sustained-release formulations for global healthcare supply.
